NCT07186023 Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural Areas
| NCT ID | NCT07186023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Health Research Institutes, Taiwan |
| Condition | Late-Life Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 124 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 124 participants in total. It began in 2025-08-01 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.
Eligibility Criteria
Inclusion Criteria for individuals participating in mindfulness-based Interventions: * Literate or have received an education above the elementary level. * Have normal or corrected vision and hearing, able to communicate and understand explanations. * Right-handed individuals as assessed by the Edinburgh Handedness Inventory. Exclusion Criteria for individuals participating in mindfulness-based Interventions: * Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease. * Individuals with neurological system disorders. * Individuals with alcohol or drug dependence. * Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months. * Individuals with metal objects in the body that cannot undergo magnetic resonance imaging (MRI), such as cardiac pacemakers, vascular clips, hearing aids, artificial joints, steel pins, etc. * Individuals with Claustrophobia. * Individuals in pregnancy or possibility of pregnancy. Inclusion Criteria for individuals participating in brain stimulation Intervention: * Individuals diagnosed with major depressive disorder by psychiatrists according to the Diagnostic and Statistical Manual, and who can cooperate with the psychiatric outpatient clinic regulations. * Literate or have received an education above the elementary level. * Have normal or corrected vision and hearing, able to communicate and understand explanations. * Right-handed individuals as assessed by the Edinburgh Handedness Inventory. * Individuals are prescribed brain stimulation therapy by clinical physicians. Exclusion Criteria for individuals participating in brain stimulation Intervention: * Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease. * Individuals with neurological system disorders. * Individuals with alcohol or drug dependence. * Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months. * Individuals with metal objects in the body that cannot undergo magnetic resonance imaging (MRI), such as cardiac pacemakers, vascular clips, hearing aids, artificial joints, steel pins, etc. * Individuals with Claustrophobia. * Individuals in pregnancy or possibility of pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07186023 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Late-Life Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07186023 currently recruiting?
Yes, NCT07186023 is actively recruiting participants. Contact the research team at alhsu@nhri.edu.tw for enrollment information.
Where is the NCT07186023 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan, Yunlin, Taiwan.
Who is sponsoring the NCT07186023 clinical trial?
NCT07186023 is sponsored by National Health Research Institutes, Taiwan. The trial plans to enroll 124 participants.